Hover a dot or row, or tab through the dots · bars scaled to the largest round ($100M)
Form D offerings
One line per offering, amendments folded in, newest first
Form D offerings
File
First filed
Latest
Sought
Sold
Investors
Exemptions
021-497362
First filed2023-11-15
Latest2023-11-15
Sought$100M
Sold$49.8M
Investors4
Exemptions506(b)
021-450686
First filed2022-06-29
Latest2022-06-29
Sought$100M
Sold$100M
Investors8
Exemptions506(b)
021-400985
First filed2021-05-27
Latest2021-05-27
Sought$80M
Sold$80M
Investors3
Exemptions506(b)
Who backs AmplifyBio, LLC, inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2023-11-15
Related persons
Name
Relationship
James Kelly Ganjei
RelationshipExecutive Officer
Lewis Von Thaer
RelationshipDirector
Matt Vaughan
RelationshipDirector
Rohan Nirody
RelationshipDirector
Shaun Rodriguez
RelationshipDirector
Facts
As its latest Form D states them
Industry
Biotechnology
State
Ohio (OH)
Exemptions
Rule 506(b)
First filed
2021-05-27
Latest filing
2023-11-15
Who backs AmplifyBio, LLC
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
Inferred investors — the funds and firms behind it, from co-filings and shared people
Every Form D and amendment as filed, with what each one stated
Its rounds in sequence: the gap between them and whether they grew
Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)